Details

Risk classification guide for drug good manufacturing practices observations - profile page - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Feb 27, 2026 · edition #6
Timestamp: 2026-02-27T09:54:59.615Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-drug-gmp-observations-0023.html
Replay URL: https://replay.healtharchive.ca/job-6/20260227095459/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-drug-gmp-observations-0023.html#ha_snapshot=625229
ID: 625229
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots